Literature DB >> 11900344

Resuscitation from severe hemorrhagic shock after traumatic brain injury using saline, shed blood, or a blood substitute.

Jeffrey B Gibson1, Robert A Maxwell, John B Schweitzer, Timothy C Fabian, Kenneth G Proctor.   

Abstract

The original purpose of this study was to compare initial resuscitation of hemorrhagic hypotension after traumatic brain injury (TBI) with saline and shed blood. Based on those results, the protocol was modified and saline was compared to a blood substitute, diaspirin cross-linked hemoglobin (DCLHb). Two series of experiments were performed in anesthetized and mechanically ventilated (FiO2 = 0.4) pigs (35-45 kg). In Series 1, fluid percussion TBI (6-8 ATM) was followed by a 30% hemorrhage. At 120 min post-TBI, initial resuscitation consisted of either shed blood (n = 7) or a bolus of 3x shed blood volume as saline (n = 13). Saline supplements were then administered to all pigs to maintain a systolic arterial blood pressure (SAP) of >100 mmHg and a heart rate (HR) of <110 beats/min. In Series 2, TBI (4-5 ATM) was followed by a 35% hemorrhage. At 60 min post-TBI, initial resuscitation consisted of either 500 mL of DCLHb (n = 6) or 500 mL of saline (n = 5). This was followed by saline supplements to all pigs to maintain a SAP of >100 mmHg and a HR of <110 beats/min. In Series 1, most systemic markers of resuscitation (e.g., SAP, HR, cardiac output, filling pressures, lactate, etc.) were normalized, but there were 0/7 vs. 5/13 deaths within 5 h (P = 0.058) with blood vs. saline. At constant arterial O2 saturation (SaO2), mixed venous O2 saturation (SvO2), cerebral perfusion pressure (CPP), and cerebral venous O2 saturation (ScvO2) were all higher, intracranial pressure (ICP) was lower, and CO2 reactivity was preserved with blood vs. saline (all P < 0.05). In Series 2, SAP, ICP, CPP, and lactate were higher with DCLHb vs. saline (all P< 0.05). Cardiac output was lower even though filling pressure was markedly elevated with DCLHb vs. saline (both P< 0.05). Neither SvO2 nor cerebrovascular CO2 reactivity were improved, and ScvO2 was lower with DCLHb vs. saline (P < 0.05). All survived at least 72 h with neuropathologic changes that included sub-arachnoid hemorrhage, midline cerebellar necrosis, and diffuse axonal injury. These changes were similar with DCLHb vs. saline. Thus, whole blood was more effective than saline for resuscitation of TBI, whereas DCLHb was no more, and according to many variables, less effective than saline resuscitation. These experimental results are comparable to those in a recent multicenter trial using DCLHb for the treatment of severe traumatic shock. Further investigations in similar experimental models might provide some plausible explanations why DCLHb unexpectedly increased mortality in patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900344     DOI: 10.1097/00024382-200203000-00013

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  11 in total

1.  Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers.

Authors:  Amy G Tsai; Pedro Cabrales; Belur N Manjula; Seetharama A Acharya; Robert M Winslow; Marcos Intaglietta
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

2.  Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice.

Authors:  Joseph N Hemerka; Xianren Wu; C Edward Dixon; Robert H Garman; Jennifer L Exo; David K Shellington; Brian Blasiole; Vincent A Vagni; Keri Janesko-Feldman; Mu Xu; Stephen R Wisniewski; Hülya Bayır; Larry W Jenkins; Robert S B Clark; Samuel A Tisherman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2012-08-10       Impact factor: 5.269

3.  Effect of a liberal versus restrictive transfusion strategy on mortality in patients with moderate to severe head injury.

Authors:  Lauralyn A McIntyre; Dean A Fergusson; James S Hutchison; Giuseppe Pagliarello; John C Marshall; Elizabeth Yetisir; Gregory M T Hare; Paul C Hébert
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 4.  Animal models of head trauma.

Authors:  Ibolja Cernak
Journal:  NeuroRx       Date:  2005-07

5.  MRI assessment of cerebral blood flow after experimental traumatic brain injury combined with hemorrhagic shock in mice.

Authors:  Lesley M Foley; Alia M Iqbal O'Meara; Stephen R Wisniewski; T Kevin Hitchens; John A Melick; Chien Ho; Larry W Jenkins; Patrick M Kochanek
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

6.  Hemorrhagic shock after experimental traumatic brain injury in mice: effect on neuronal death.

Authors:  Alia Marie Dennis; M Lee Haselkorn; Vincent A Vagni; Robert H Garman; Keri Janesko-Feldman; Hülya Bayir; Robert S B Clark; Larry W Jenkins; C Edward Dixon; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2009-06       Impact factor: 5.269

7.  A systematic review of large animal models of combined traumatic brain injury and hemorrhagic shock.

Authors:  Andrew R Mayer; Andrew B Dodd; Meghan S Vermillion; David D Stephenson; Irshad H Chaudry; Denis E Bragin; Andrew P Gigliotti; Rebecca J Dodd; Benjamin C Wasserott; Priyank Shukla; Rachel Kinsler; Sheila M Alonzo
Journal:  Neurosci Biobehav Rev       Date:  2019-06-27       Impact factor: 8.989

Review 8.  Experimental trauma models: an update.

Authors:  Michael Frink; Hagen Andruszkow; Christian Zeckey; Christian Krettek; Frank Hildebrand
Journal:  J Biomed Biotechnol       Date:  2011-01-26

9.  Incidence of low central venous oxygen saturation during unplanned admissions in a multidisciplinary intensive care unit: an observational study.

Authors:  Hendrik Bracht; Matthias Hänggi; Barbara Jeker; Ninja Wegmüller; Francesca Porta; David Tüller; Jukka Takala; Stephan M Jakob
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.